From Screening to Therapy: How AI Is Transforming Breast Cancer Detection and Treatment Decisions
From Screening to Therapy: How AI Is Transforming Breast Cancer Detection and Treatment Decisions
Publish Date: 2026-06-07 17:00:00
Source Domain: www.docwirenews.com
Transcript
How is artificial intelligence currently improving early detection and risk stratification in breast cancer?
Dr. Kurian: I think, when you look at the use of artificial intelligence within oncology, amongst all of the current FDA-approved machine learning devices, radiology is really the first one that you really think of in terms of early detection within mammography with lung cancer screening, other things. That’s really where the majority of these devices are created at this point in time, which is really important as well, too. And you know, we now have tools like Clairity, you know, coming in onto the market and more to come, I think within the breast space, too.
What’s your thought?
Dr. Hundal: Yeah, no I agree with that. And also, like how radiology and pathology, like in the integration of both things in terms of like prognostic and risk stratification, since you’ve seen like Artera AI kind of like combining both in the prostate cancer world and also in breast cancer now, right? It got recently in FDA program, I believe, right? So like not yet an NCCN, but like hopefully, down the road with more of like group projects and like research that goes on, go see more integration.
Dr. Kurian: I think personalized screening, I think, is gonna become very important. So, the WISDOM trial was one that really looked at this first approach of personalized screening, and there’s still things that we need to work out from that, but I think it really laid a foundation for what we can accomplish in the future, and attaching artificial intelligence to an approach like that, I think, will be quite powerful.
Dr. Hundal: Yeah, and it can also help our patients like who needs every six months an MRI, mammogram, and kind of like what kind of path they’re on.
In what ways are AI-driven tools influencing treatment decision-making in breast oncology—for example, in selecting between surgical options, radiation, or systemic therapies?
Dr. Kurian: So, I…
